Harpoon Therapeutics, Inc. (NASDAQ:HARP) Receives $24.75 Average Price Target from Brokerages
Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six analysts that are covering the company,...
Slate Office REIT (TSE:SOT.UN) Receives C$1.26 Consensus PT from Brokerages
Shares of Slate Office REIT (TSE:SOT.UN – Get Free Report) have been given an average rating of “Reduce” by the six analysts that are currently...
Brokerages Set Canadian Natural Resources Limited (NYSE:CNQ) Price Target at $94.00
Shares of Canadian Natural Resources Limited (NYSE:CNQ – Get Free Report) (TSE:CNQ) have earned a consensus recommendation of “Hold” from the six research firms that...
Black Diamond Group (TSE:BDI) Sets New 12-Month High on Analyst Upgrade
Black Diamond Group Limited (TSE:BDI – Get Free Report) shares reached a new 52-week high on Friday after BMO Capital Markets raised their price target...
Desjardins Research Analysts Lift Earnings Estimates for Canadian Pacific Kansas City Limited (TSE:CP)
Canadian Pacific Kansas City Limited (TSE:CP – Free Report) (NYSE:CP) – Equities research analysts at Desjardins boosted their FY2026 EPS estimates for Canadian Pacific Kansas...
Equities Analysts Set Expectations for Protagonist Therapeutics, Inc.’s FY2028 Earnings (NASDAQ:PTGX)
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Stock analysts at Capital One Financial issued their FY2028 earnings per share estimates for shares of Protagonist...